A further investigation on a MALDI-based method for evaluation ofmarkers of renal damage

Journal of Mass Spectrometry

Volumn 44, Issue 12, 2009, Pages 1754-1760

  Lapolla, Annunziata ^a   Molin, Laura ^b   Sechi, Annalisa ^a   Cosma, Chiara ^a   Ragazzi, Eugenio ^a   Seragliad, Roberta ^c   Traldid, Pietro ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b ISB Ion Source and Biotechnologies   (Italy)

^c CNR   (Italy)

Author keywords

Collagen; MALDI MS; Precursor; Renal damage; Urinary protein profile; Uromodulin precursor

Indexed keywords

ABUNDANCE RATIOS; CORRELATION COEFFICIENT; CUT-OFF VALUE; DIABETIC PATIENT; FALSE POSITIVE RATES; HEALTHY CONTROLS; HEALTHY SUBJECTS; INVERSE RELATIONSHIP; IONIC SPECIES; MALDI-MS; MICROALBUMINURIA; NEPHROPATHY; P-VALUES; RECEIVER OPERATING CHARACTERISTICS; RENAL DAMAGE; RENAL DISEASE; SCATTER PLOT MATRIX; TRUE POSITIVE RATES; URINARY PROTEINS; UROMODULIN;

COLLAGEN;

SUGAR (SUCROSE);

BIOLOGICAL MARKER; COLLAGEN; COLLAGEN ALPHA 5; COLLAGEN ALPHA1 CHAIN; TAMM HORSFALL GLYCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FALSE POSITIVE RESULT; HUMAN; KIDNEY DISEASE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROALBUMINURIA; PRECURSOR; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY; URINALYSIS; VALIDITY;

AGED; AGED, 80 AND OVER; ALBUMINURIA; BIOLOGICAL MARKERS; COLLAGEN TYPE I; COLLAGEN TYPE V; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY DISEASES; LOGISTIC MODELS; MIDDLE AGED; MUCOPROTEINS; PROCOLLAGEN; PROTEINURIA; ROC CURVE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 72449143576     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1685     Document Type: Article

References (13)

1. R. G. Langlois, J. E. Trebes, E. A. Dalmasso, Y. Ying, R. W. Davies, M. P. Curzi, B. W. Colston, K. W. Turteltaub, J. Perkins, B. A. Chromy, M. W. Choi, G. A. Murphy, J. P. Fitch, S. L. McCutchen-Maloney. Serum protein profile alteration in hemodialysis patients. American Journal of Nephrology 2004, 24, 268.
2. H. Mischak, T. Kaiser, M. Walden, M. Hillmann, S. Wittke, A. Herrmann, S. Knueppel, H. Haller, D. Fliser. Proteomic analysis for the assessment of diabetic renal damage in humans. Clinical Science 2004, 107, 485.
3. M. Meier, T. Kaiser, A. Herrmann, S. Knueppel, M. Hillmann, P. Koester, T. Danne, H. Haller, D. Friser, H. Mischak. Identification of urinary protein pattern in Type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. Journal of Diabetes and its Complications 2005, 19, 223.
4. K. Rossing, H. Mischak, H. H. Parving, P. K. Christensen, M. Walden, M. Hillmann, T. Kaiser. Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney International 2005, 68, 193.
5. H. H. Out, H. Can, D. Spentzos, R. G. Nelson, R. L. Hanson, H. C. Looker, W. C. Knowler, M. Monroy, T. A. Libermann, S. A. Karumanchi, R. Thadhani. Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 2007, 30, 638.
6. P. V. Rao, X. Lu, M. Standley, P. Pattee, G. Neelima, G. Girisesh, K. V. Dakshinamurthy, C. T. Roberts, S. R. Nagalla. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007, 30, 629.
7. S. A. Varghese, T. B. Powell, M. N. Budisavljevic, J. C. Oates, J. R. Raymond, J. S. Almeida, J. M. Arthur. Urine biomarkers predict the cause of glomerular disease. Journal of American Society of Nephrology 2007, 18, 913.
8. K. Rossing, H. Mischak, M. Dakna, P. Zürbig, J. Novak, B. A. Julian, D. M. Good, J. J. Coon, L. Tarnow, P. Rossing. Urinary proteomics in diabetes and CKD. Journal of the American Society of Nephrology 2008, 19, 1283.
9. A. Lapolla, R. Seraglia, L. Molin, K. Williams, C. Cosma, R. Reitano, A. Sechi, E. Ragazzi, P. Traldi. Low molecular weight proteins in urines from healthy subjects, diabetic, nephropathic and diabetic nephropathic patients: a MALDI study. Journal of Mass Spectrometry 2009, 44, 419.
10. J. A. Hanley, B. J. McNeil. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143, 29.
11. J. Metzger, J. P. Schanstra, H. Mischak. Capillary electrophoresis mass spectrometry in urinary proteome analysis: current applications and future developments. Analytical and Bioanalytical Chemistry 2009, 393, 1431.
12. E. M. Weissinger, S. Wittke, T. Kaiser, H. Haller, S. Bartel, R. Krebs, I. Golovko, H. D. Rupprecht, M. Haubitz, H. Hecker, H. Mischak, D. Fliser. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney International 2004, 65, 2426.
13. M. Haubitz, S. Wittke, E. M. Weissinger, M. Walden, H. D. Rupprecht, J. Floege, H. Haller, H. Mischak. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney International 2005, 67, 2313.